Sage Journals: Discover world-class research

Abstract

Spanish

OBJECTIVE:

Nuclear pharmacy is practiced in every hospital with a nuclear medicine clinic. Pharmacists control this practice in fewer than four percent of these institutions. The authors wish to bring to the attention of hospital pharmacists an area of practice in which they can make a significant contribution to the state of pharmacy practice.

METHOD:

The current state of the physician practice of nuclear pharmacy is described and compared with the accepted standards of pharmacy practice.

CONCLUSIONS:

Hospital pharmacists can improve pharmaceutical care administered in nuclear medicine by their participation in nuclear pharmacy practice and by the application of hospital pharmacy practice standards. It is also suggested that nuclear pharmacy should be integrated into the pharmacy curriculum at schools of pharmacy.

Get full access to this article

View all access options for this article.

References

Briner

. Radioactive materials: New dimensions for pharmacy. Hosp Top 1965; 43 (6):79–90.

Quinn

. The role of the hospital radiopharmacy. In: Quinn

ed. Year book of nuclear medicine 1970. Chicago: Year Book Medical Publishers, 1970: 5–13.

Cruz

Winship

. The status of radiopharmacy as viewed by nuclear medicine directors. Hosp Pharm 1977; 12: 342–56.

Drug-use control by pharmacists for all prescription drugs. Am Pharm 1989; NS29: 66.

ASHP technical assistance bulletin on hospital drug distribution and control. In: Practice standards of ASHP. Bethesda, MD: American Society of Hospital Pharmacists, 1988: 137–47.

Accreditation manual for hospitals, 1989. Chicago: Joint Commission on the Accreditation of Healthcare Organizations, 1988: 169–88.

Rules of the board of regents (New York State), part 63: pharmacy, section 63.6.

Nuclear pharmacy certification examination candidate's guide. Washington, DC: Board of Pharmaceutical Specialties, 1988: 2.

Kavula

Laven

Hladik

Shaw

Hoogland

Petry

. Guidelines for nuclear pharmacy training. Educational Affairs Committee, Section on Nuclear Pharmacy. Washington, DC: American Pharmaceutical Association, 1987–88.

10.

Special requirements for residency training in nuclear medicine. In: 1990–1991 Directory of graduate medical education programs. Chicago: American Medical Association, 1990: 71–3.

11.

Essentials and guidelines of an accredited educational program for the nuclear medicine technologist. Salt Lake City: Joint Review Committee on Educational Programs in Nuclear Medicine Technology, 1984: 5–7.

12.

National Coordinating Committee on Large Volume Parenterals. Recommended methods for compounding intravenous admixtures in hospitals. Am J Hosp Pharm 1975; 32: 261–70.

13.

Regulatory guide 10.8, guide for the preparation of applications for medical use programs. Washington, DC: US Nuclear Regulatory Commission, 1987: EXH-11.

14.

Title 10 of the code of federal regulations, part 35, section 35.61, 1988.

15.

Accreditation manual for hospitals, 1989. Chicago: Joint Commission on the Accreditation of Healthcare Organizations, 1988: 125–30.

16.

Crawford

. ASHP national survey of hospital-based pharmaceutical services—1990. Am J Hosp Pharm 1990; 47: 2665–95.

17.

Laven

Shaw

. Detection of drug interactions involving radiopharmaceuticals: A professional responsibility of the clinical pharmacist. J Pharm Pract 1989; 2: 287–98.

18.

Title 10 of the code of federal regulations, part 35, section 35.1, 1988.

19.

Title 10 of the code of federal regulations, part 20, section 20.3, 1988.

Hospital Nuclear Pharmacy—A Comparison of Physician and Pharmacist Practice